What is the procedure for bilateral sacroiliac joint injections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bilateral Sacroiliac Joint Injection Procedure

Bilateral SI joint injections should be performed under fluoroscopic guidance using a contralateral oblique view of 5-20 degrees to superimpose the posterior and anterior joint lines, targeting the inferior aspect of the joint with approximately 1.4mL of injectate per side. 1

Image Guidance Selection

Fluoroscopy is the preferred imaging modality for SI joint injections, as it allows real-time confirmation of intra-articular needle placement and exclusion of intravascular positioning through contrast injection prior to therapeutic injectate delivery 1. While ultrasound and CT guidance are alternatives, fluoroscopy provides superior workflow and verification capabilities.

Alternative Imaging Modalities:

  • Ultrasound guidance: Shows no difference in clinical outcomes compared to fluoroscopy, but has lower accuracy (50% vs 65% confirmed intra-articular placement) 1
  • CT fluoroscopy: Achieves high technical success with median procedural time of 6.72 minutes for bilateral injections and low radiation exposure (0.11 mSv) 2
  • 3D cone-beam CT with fluoroscopy fusion: Provides excellent accuracy with 87% achieving >50% pain relief 3

Fluoroscopic Technique - Step by Step

Patient Positioning:

  • Position patient prone on fluoroscopy table

C-Arm Positioning:

  • Rotate C-arm to contralateral oblique view of 5-20 degrees to superimpose the posterior and anterior SI joint lines, creating a lucency that represents the target 1
  • Alternative approach: If joint lines cannot be superimposed despite exploring various oblique angles, the medial joint line may correspond to the posterior aspect of the joint 1

Target Selection:

  • Target the inferior aspect of the joint (most commonly used approach) 1
  • The proper puncture level is approximately 1.69 cm ± 0.63 cm above the lower edge of the joint 4
  • Alternative access points (mid-portion or superior portion) are more challenging due to lack of synovium 1

Needle Insertion:

  • Insert needle under fluoroscopic guidance toward the identified target
  • Advance until intra-articular position is achieved

Confirmation:

  • Inject contrast medium first to confirm intra-articular placement and rule out intravascular positioning 1
  • Observe for contrast spread pattern
  • Cephalad extension of contrast may correlate with improved short-term outcomes (2 weeks), though this advantage disappears by 8 weeks 1

Injectate Administration:

  • Volume: Limit to approximately 1.4mL per joint (range 0.6-2.7mL) to avoid extra-articular spread 1
  • Common therapeutic injectate: Corticosteroid (e.g., 40mg triamcinolone acetonide) with or without local anesthetic 5
  • Volumes exceeding joint capacity will reach adjacent unintended structures, potentially altering outcomes 1

Bilateral Procedure Considerations

When performing bilateral injections:

  • Median procedural time: 6.72 minutes (range 4.17-21.17 minutes) 2
  • Radiation exposure: Median 0.11 mSv (range 0.09-0.51 mSv) for bilateral procedures 2
  • Repeat the same technique for the contralateral side
  • Consider staging if patient tolerance is a concern, though bilateral same-session injections are standard practice

Critical Pitfalls to Avoid

  1. Extra-articular injection: Palpation-guided injections have poor accuracy and should not be used 1. Even with imaging, accuracy varies (fluoroscopy 65%, ultrasound 50%) 1

  2. Excessive volume: Injecting >1.4mL risks extra-capsular spread, potentially causing transient sciatic nerve block from anterior capsular disruption 1

  3. Patient selection error: Only 15-30% of patients with suspected SI joint pain have true SI joint pathology 1. Patients who fail to achieve positive diagnostic anesthetic block are unlikely to benefit from therapeutic corticosteroid injection 1

  4. Skipping contrast confirmation: Without contrast verification, you cannot confirm intra-articular placement or exclude intravascular positioning

Safety Profile

Common adverse events include 1:

  • Injection site pain (most common)
  • Vasovagal reaction (2.5% incidence)
  • Facial flushing/sweating (corticosteroid-related)
  • Transient sciatic nerve block (when using local anesthetic, 6.3% in some series)

Serious complications are rare but include infection and epidural abscess in immunosuppressed patients 1. Bleeding risk is low; most guidelines recommend continuing anticoagulation 1.

Related Questions

In a 46-year-old woman presenting to the emergency department with severe right upper quadrant abdominal pain, fever, scleral icterus, and elevated alkaline phosphatase and bilirubin, what is the most likely diagnosis?
What is the comprehensive protocol for performing a lower‑extremity arterial Doppler ultrasound in an adult patient?
How should a 2-year-old child presenting with a dry cough and wheezing be managed?
In an 82-year-old patient with cyanotic lips despite a pulse‑oximeter reading of 100%, what is the appropriate immediate management?
What are the indications, contraindications, and procedural steps for performing a bone marrow aspiration?
When should HOMA‑IR (Homeostatic Model Assessment of Insulin Resistance) be used instead of HbA1c (glycated hemoglobin) for diagnosing, screening, or monitoring diabetes?
An 80-year-old man presents with weakness, severe anemia, thrombocytopenia, and mild leukopenia, with normal liver function tests and normal renal function; what is the likely cause and how should it be evaluated?
How is patient-prosthesis mismatch assessed using aortic annulus size indexed to body surface area?
How do I distinguish flexor carpi ulnaris tendonitis from extensor carpi ulnaris tendonitis and what is the recommended initial treatment?
Should the Candida albicans and Staphylococcus aureus identified in a vaginal culture be treated?
What does holodiastolic flow reversal in the descending aorta indicate and what is the recommended evaluation and management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.